IL1B and neoplasm: Moreover, chemotherapy treatment of tumor cells (e.g., with oxaliplatin and anthracyclines) can cause tumor cells to release ATP, which is an activation signal for the NLRP3 inflammasome and the IL-1β/IL-1 receptor (IL1R) signaling axis in dendritic cells (DCs) (59).